Delivering precision medicine for lung cancers
The Australasian Lung Cancer Trials Group’s (ALTG) Annual Scientific Meeting (ASM) brings together leading cancer health professionals for a two-day educational experience, providing access to the cutting-edge innovations in lung and thoracic cancers.
International guest speakers
- Dr. Alexander Drilon – Clinical Director, Early Drug Development Service, Memorial Sloan Kettering Cancer Centre
- Prof. Qing Zhou – Secretary-general of Chinese Thoracic Oncology Group
Abstract submissions are now closed.
The program, which features three plenary sessions – Patient Centered Precision Medicine, New Targets in Lung Cancer and Approaches to Overcoming Resistance – here.